scholarly journals Association of Escherichia coli J5-Specific Serum Antibody Responses with Clinical Mastitis Outcome for J5 Vaccinate and Control Dairy Cattle

2008 ◽  
Vol 16 (2) ◽  
pp. 209-217 ◽  
Author(s):  
David J. Wilson ◽  
Bonnie A. Mallard ◽  
Jeanne L. Burton ◽  
Ynte H. Schukken ◽  
Yrjo T. Grohn
Keyword(s):  
Escherichia Coli ◽  
Dairy Cattle ◽  
Milk Production ◽  
Specific Antibody ◽  
Serum Antibody ◽  
Clinical Mastitis ◽  
Immunoglobulin M ◽  
Antibody Responses ◽  
Enzyme Linked Immunosorbent Assay ◽  
And Control

ABSTRACT Dairy cattle in two commercial Holstein herds were randomly selected to be vaccinated twice with J5, at approximately 60 days and 28 days before the expected calving date, or to be untreated controls. Based on whether milk production changed following clinical mastitis or whether cows were culled or died within 30 days after onset, 51 mastitis cases were classified as severe or mild. J5-specific antibody responses were evaluated by enzyme-linked immunosorbent assay of all 32 severe and 19 mild cases. The amounts of J5-specific immunoglobulin M (IgM), IgG1, and IgG2 antibodies in sera from the 27 J5 vaccinates were compared with those of the 24 controls. At drying off (before J5 vaccination), all cows had similar amounts of J5-specific antibody. Immediately after calving (approximately 28 days after the second vaccination), J5 vaccinates had significantly higher production of J5-specific IgG1 and IgG2 than controls. When cows were tested following clinical mastitis, none of the three antibody classes differed significantly between the controls and the vaccinates. Vaccinates that contracted Escherichia coli mastitis had 75% less milk loss than controls. The cows that contracted clinical mastitis later in lactation, the unvaccinated controls, and those infected with E. coli had more milk loss following mastitis. The hazards of being culled for all reasons and of being culled for mastitis were significantly lower for J5 vaccinates. Vaccination with J5 was associated with protection against milk production loss and culling following clinical mastitis, and it was also significantly associated with changes in J5-specific IgM, IgG1, and IgG2 antibodies in sera of vaccinated cows.

scholarly journals Milk Production Change Following Clinical Mastitis and Reproductive Performance Compared Among J5 Vaccinated and Control Dairy Cattle

2008 ◽  
Vol 91 (10) ◽  
pp. 3869-3879 ◽  
Author(s):  
D.J. Wilson ◽  
Y.T. Grohn ◽  
G.J. Bennett ◽  
R.N. González ◽  
Y.H. Schukken ◽  
...  
Keyword(s):  
Dairy Cattle ◽  
Milk Production ◽  
Reproductive Performance ◽  
Clinical Mastitis ◽  
And Control ◽  
Production Change

scholarly journals Antibody Responses in Reindeer (Rangifer tarandus) Infected with Mycobacterium bovis

2005 ◽  
Vol 12 (6) ◽  
pp. 727-735 ◽  
Author(s):  
W. R. Waters ◽  
M. V. Palmer ◽  
J. P. Bannantine ◽  
R. Greenwald ◽  
J. Esfandiari ◽  
...  
Keyword(s):  
Mycobacterium Bovis ◽  
Specific Antibody ◽  
Rangifer Tarandus ◽  
Skin Testing ◽  
Serum Antibody ◽  
The United States ◽  
Antibody Responses ◽  
Enzyme Linked Immunosorbent Assay ◽  
Cell Mediated Immunity ◽  
Testing Procedures

ABSTRACT Despite having a very low incidence of disease, reindeer (Rangifer tarandus) are subject to tuberculosis (TB) testing requirements for interstate shipment and herd accreditation in the United States. Improved TB tests are desperately needed, as many reindeer are falsely classified as reactors by current testing procedures. Sera collected sequentially from 11 (experimentally) Mycobacterium bovis-infected reindeer and 4 noninfected reindeer were evaluated by enzyme-linked immunosorbent assay (ELISA), immunoblotting, and multiantigen print immunoassay (MAPIA) for antibody specific to M. bovis antigens. Specific antibody was detected as early as 4 weeks after challenge with M. bovis. By MAPIA, sera were tested with 12 native and recombinant antigens, which were used to coat nitrocellulose. All M. bovis-infected reindeer developed responses to MPB83 and a fusion protein, Acr1/MPB83, and 9/11 had responses to MPB70. Other antigens less commonly recognized included MPB59, ESAT-6, and CFP10. Administration of purified protein derivatives for skin testing boosted serum antibody responses, as detected by each of the assays. Of the noninfected reindeer, 2/4 had responses that were detectable immediately following skin testing, which correlated with pathological findings (i.e., presence of granulomatous lesions yet the absence of acid-fast bacteria). The levels of specific antibody produced by infected reindeer appeared to be associated with disease progression but not with cell-mediated immunity. These findings indicate that M. bovis infection of reindeer elicits an antibody response to multiple antigens that can be boosted by skin testing. Serological tests using carefully selected specific antigens have potential for early detection of infections in reindeer.

scholarly journals Milk and Serum J5-Specific Antibody Responses, Milk Production Change, and Clinical Effects following Intramammary Escherichia coli Challenge for J5 Vaccinate and Control Cows

2007 ◽  
Vol 14 (6) ◽  
pp. 693-699 ◽  
Author(s):  
David J. Wilson ◽  
Bonnie A. Mallard ◽  
Jeanne L. Burton ◽  
Ynte H. Schukken ◽  
Yrjo T. Gröhn
Keyword(s):  
Escherichia Coli ◽  
Milk Production ◽  
Statistical Significance ◽  
Antibody Responses ◽  
Clinical Effects ◽  
Early Lactation ◽  
E Coli ◽  
Significant Difference ◽  
Specific Immunoglobulin ◽  
And Control

ABSTRACT Holstein dairy cows (four J5 vaccinates and four controls) selected for no recorded intramammary disease and low somatic cell count (SCC) during the previous lactation were challenged by intramammary infusion of Escherichia coli. Vaccination with J5 was at 8 weeks and again 4 weeks before the anticipated calving date. Cows were challenged at 8 to 16 days in milk (DIM). Shedding of E. coli in milk was significantly higher among controls than vaccinates (no shedding) from 6 h to 21 h postchallenge. From 21 h to 132 h postchallenge, SCC in challenged quarters of controls (5,429,000/ml) was significantly higher than that of vaccinates (490,000/ml). On the day after challenge, milk production in control cows was 8 kg less, while vaccinates gained 0.5 kg, a significant difference. In serum immediately prior to challenge, J5-specific immunoglobulin G1 (IgG1) was significantly higher, IgG2 was nearly significantly higher, and IgM was the same in J5 vaccinates relative to controls. Vaccinates had proportionally more IgG2 in serum postcalving and in the first 12 h following challenge and less IgG2 in milk 24 h after challenge than the controls, approaching statistical significance. The ratio of J5-specific IgG1 and IgG2 combined compared to IgM was significantly higher in vaccinates than in controls in prechallenge serum (ratios of 15.8 and 3.2, respectively) and milk (5.0 and 1.3, respectively). Cows with higher IgM titers in milk 12 h postchallenge produced significantly less milk. Vaccination with J5 was significantly associated with higher production of J5-specific IgG1 and IgG2 in early lactation, reduced SCC, faster clearance of E. coli from milk, and less milk production loss following intramammary challenge.

scholarly journals The microbiome of Escherichia coli and culture-negative nonsevere clinical mastitis: Characterization and associations with linear score and milk production

2019 ◽  
Vol 102 (1) ◽  
pp. 578-594 ◽  
Author(s):  
A.K. Vasquez ◽  
E.K. Ganda ◽  
M.B. Capel ◽  
S. Eicker ◽  
P.D. Virkler ◽  
...  
Keyword(s):  
Escherichia Coli ◽  
Milk Production ◽  
Clinical Mastitis ◽  
Culture Negative

scholarly journals Seroprevalence of major infectious causes of dairy cattle reproductive problems in central Ethiopia 

2021 ◽  
Author(s):  
Yohannes Equar Messele ◽  
Gebrerufael Girmay ◽  
Bezina Arega Emeru ◽  
Shelema Kelbesa Bora ◽  
Workitu Firomsa Gudeta ◽  
...  
Keyword(s):  
Dairy Cattle ◽  
Q Fever ◽  
Neospora Caninum ◽  
Control Program ◽  
Enzyme Linked Immunosorbent Assay ◽  
Serum Samples ◽  
Central Ethiopia ◽  
History Of ◽  
Combined Infection ◽  
And Control

Abstract Background Reproductive problem is one of the main constraints of livestock genetic improvement efforts in tropical countries. The aim of this study was to determine the prevalence of major infectious causes of reproductive problems of dairy cattle in selected dairy farms in central Ethiopia. Overall 86 serum samples were collected from October 2018 to February 2019 from animals with history of reproductive problems. The collected serum was tested for antibody titer against Brucella species, Neospora caninum, Bovine Viral Diarrhea (BVD), Infectious Bovine Rhinotracheitis (IBR) and Q-fever using rose-bengal and enzyme-linked immunosorbent assay (ELISA) tests. Result Among the animals with the history of reproductive disordered; abortion, still birth and repeat breeding cases were found in 61.6%, 19.8% and 18.6%, respectively. The prevalence of IBR, BVD, Neospora caninum and Coxiella brunetti was found to be 79.1%, 38.4%, 3.5% and 1.2%, respectively. The combined infection of both BVD and IBR were detected in 21% of animals. Out of the total animals examined in this study, 95.9% of Jersey breeds were found seropositive to IBR than Boran-Friesian crosses (57.7%). The incidence of BVD was significantly higher in Boran-Friesian crossbred cattle than in Jersey which was found to be 69.3% and 14.3, respectively. The prevalence of IBR and BVD was directly proportional with age of the animal and parity. Conclusion Vaccination against IBR and BVD is not practiced in Ethiopia, the rising level of those diseases in dairy sector needs regular surveillance and control program.

Expression of meningococcal epitopes in LamB of Escherichia coli and the stimulation of serosubtype-specific antibody responses

1993 ◽  
Vol 10 (1) ◽  
pp. 203-213 ◽  
Author(s):  
J. McCarvil ◽  
A. J. McKenna ◽  
C. Grief ◽  
C. S. Hoy ◽  
D. Sesardic ◽  
...  
Keyword(s):  
Escherichia Coli ◽  
Specific Antibody ◽  
Antibody Responses ◽  
Stimulation Of

scholarly journals 405. Serum Antibody Responses Against Carbapenem-Resistant Klebsiella pneumoniae in Infected Patients

2019 ◽  
Vol 6 (Supplement_2) ◽  
pp. S206-S206
Author(s):  
Kasturi Banerjee ◽  
Michael Motley ◽  
Elizabeth Diago-Navarro ◽  
Bettina C Fries
Keyword(s):  
Therapeutic Potential ◽  
Serum Antibody ◽  
Antibody Responses ◽  
Size Exclusion ◽  
Enzyme Linked Immunosorbent Assay ◽  
Affinity Column ◽  
Carbapenem Resistant ◽  
Potential Vaccine ◽  
Clade 1 ◽  
Humoral Responses

Abstract Background Capsular polysaccharide (CPS) of Carbapenem-resistant K. pneumoniae ST258 (CR-Kp) is a potential vaccine target. CPS of these isolates generally falls within 2 homology groups named clade 1 and clade 2. We and others have made antibodies (Abs) that act against clade2 CR-Kp but failed to make therapeutic Abs against clade1 CR-Kp. Previous studies had shown that studying patient’s antibody responses could help in identifying suitable candidates for developing immunotherapies. Thus, we sought to identify potential vaccine candidates by investigating the humoral response CPS in CR-Kp-infected patients. Methods 24 CR-Kp isolates and corresponding serums were collected from inpatients at Stony Brook Hospital. CPS was isolated and purified by size-exclusion column chromatography from CR-Kp strains 34 (clade 2), 36 (clade 1), and 38 (clade-Other). Anti-CPS Abs in patient’s serum were detected by enzyme-linked immunosorbent assay (ELISA) and bulk Abs from positive serum were purified using an affinity column. These Abs were tested for activity against CR-Kp by serum bactericidal and agglutination assays. Results 50% of clade2 CR-Kp-infected patients had humoral responses against CPS34. 77% of clade 1-infected patients sera cross-reacted wtih CPS34, but none of them developed Abs against CPS36. Interestingly, 90% of clade1 and 60% of clade 2-infected patients, respectively, showed Abs binding to CPS38. Thus, we selectively purified Anti-CPS Abs from two clade-Other-infected patients and observed that they were cross-reactive with all three CPS. Further, these Anti-CPS Abs agglutinated all tested CR-Kp isolates (34, 36, and 38) when compared with control human IgG (P < 0.005). Additionally, these Anti-CPS Abs promoted killing of clade2 bacteria and inhibited the growth of clade1 bacteria in Ab-mediated serum bactericidal assay. These data elucidate that humoral responses developed in clade-Other CR-Kp-infected patients have therapeutic potential. Conclusion With the unavailability of effective antimicrobials for CR-Kp, approaches like developing novel anti-CPS vaccine could serve as an alternate therapy. Our data suggest that developing immunotherapies targeting CPS38 could potentially provide protection across both clade1 and clade2 bacteria in clinical settings. Disclosures All authors: No reported disclosures.

scholarly journals Serum Antibody Responses in Children with Rotavirus Diarrhea Can Serve as Proxy for Protection

2005 ◽  
Vol 12 (2) ◽  
pp. 273-279 ◽  
Author(s):  
J. Xu ◽  
P. Dennehy ◽  
H. Keyserling ◽  
L. E. Westerman ◽  
Y. Wang ◽  
...  
Keyword(s):  
Acute Phase ◽  
Severe Disease ◽  
Serum Antibody ◽  
Immunoglobulin M ◽  
Antibody Responses ◽  
Serum Samples ◽  
Convalescent Phase ◽  
Conversion Rates ◽  
Reliable Marker ◽  
Rotavirus Diarrhea

ABSTRACT We examined sera from 42 patients 1 to 30 months of age for rotavirus immunoglobulin M (IgM), IgA, IgG, and IgG subclasses and sought to determine if serum antibody could serve as a reliable marker for prediction of disease severity. Infants in the first few months of life usually had high maternal IgG titers and, when they were infected with rotavirus, had low IgM titers or no IgM in acute-phase sera and poor seroconversions 3 weeks later, suggesting that maternal antibodies had inhibited viral replication and antibody responses. All patients ≥6 months of age had IgM in acute-phase sera, indicating that IgM is a good marker for acute rotavirus infection. IgG was the best overall predictor of an infection, as the convalescent-phase sera of 81% of the patients had a fourfold rise in the IgG titer. IgA titers in convalescent-phase sera and conversion rates were higher among patients ≥12 months of age than among children younger than 12 months. IgG1 was the predominant subclass detected in the acute-phase sera of some children and in all 28 convalescent-phase serum samples examined. Patients with preexisting acute-phase IgG titers of ≥100 or ≥200 had diarrhea that was less severe or of a shorter duration. These results indicate that serum IgG is the most reliable marker for seroconversion and is a consistent proxy for protection against severe disease.

Sign in / Sign up

Export Citation Format

Share Document